Profile for Singapore Patent: 11201602937U
✉ Email this page to a colleague
US Patent Family Members and Approved Drugs for Singapore Patent: 11201602937U
| US Patent Number | US Expiration Date | US Applicant | US Tradename | Generic Name |
|---|---|---|---|---|
| ⤷ Start Trial | Oct 15, 2034 | Blueprint Medicines | AYVAKIT | avapritinib |
| ⤷ Start Trial | Oct 15, 2034 | Blueprint Medicines | AYVAKIT | avapritinib |
| ⤷ Start Trial | Oct 15, 2034 | Blueprint Medicines | AYVAKIT | avapritinib |
| ⤷ Start Trial | Oct 15, 2034 | Blueprint Medicines | AYVAKIT | avapritinib |
| >US Patent Number | >US Expiration Date | >US Applicant | >US Tradename | >Generic Name |
